Breast Cancer - Moose and Doc

A breast cancer explanations website

 

By Dr. Halls

References

 

  • Barchielli A, Federico M, De Lisi V, Bucchi L, Ferretti S, Paci E, Ponti A, Buiatti E. (2005) In situ breast cancer: incidence trend and organised screening programmes in Italy. Eur J Cancer (May 2005) 41(7):1045-50. https://www.ncbi.nlm.nih.gov/pubmed/15862754
  • Dawood S, Broglio K, Gonzalez-Angulo AM, Kau SW, Yang W, Albarracin C, Meric F, Hortobagyi G, Theriault R. (2008) Development of new cancers in patients with DCIS: the M.D. Anderson experience. Ann Surg Oncol. 2008 Jan;15(1):244-9. Epub 2007 Nov 28. https://www.ncbi.nlm.nih.gov/pubmed/18043978
  • Duffy SW, Agbaje O, Tabar L, Vitak B, Bjurstam N, Björneld L, Myles JP, Warwick J. (2005) Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res. 2005;7(6):258-65. Epub 2005 Nov 10. https://www.ncbi.nlm.nih.gov/pubmed/16457701
  • Ernster VL, Barclay J, Kerlikowske K, (et al). (1996) Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA. 1996 Mar 27;275(12):913-8. https://www.ncbi.nlm.nih.gov/pubmed/8598618
  • Glass AG, Lacey JV, Carreon D, Hoover RN. (2007) Breast Cancer Incidence, 1980–2006: Combined Roles of Menopausal Hormone Therapy, Screening Mammography, and Estrogen Receptor Status J Natl Cancer Inst (2007) 99 (15): 1152-1161. https://academic.oup.com/jnci/article/99/15/1152/1006785/Breast-Cancer-Incidence-1980-2006-Combined-Roles
  • Jemal A, Ward E, Thun MJ. (2007) Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res. 2007;9(3):R28. https://www.ncbi.nlm.nih.gov/pubmed/17477859
  • Jones ME, Schoemaker MJ, Wright L, McFadden E, Griffin J, Thomas D (et al). (2016) Menopausal hormone therapy and breast cancer: what is the true size of the increased risk? British Journal of Cancer (2016) 115, 607–615. http://www.nature.com/bjc/journal/v115/n5/full/bjc2016231a.html
  • Paquette D, Snider J, Bouchard F, Olivotto H. (et al). (2000) Performance of screening mammography in organized programs in Canada in 1996 CMAJ. 2000 Oct 31; 163(9): 1133–1138. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC80245/
  • Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women’s Health Initiative Investigators. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002 Jul 17;288(3):321-33. https://www.ncbi.nlm.nih.gov/pubmed/12117397
  • Schairer C, Mink PJ, Carroll L, Devesa SS. (2004) Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst. 2004 Sep 1;96(17):1311-21. https://www.ncbi.nlm.nih.gov/pubmed/15339969
  • U.S. National Institutes of Health. (2005) Breast Cancer Surveillance Consortium Statistics, 2005.
  • Trentham-Dietz A, Sprague BL, Alagoz O, Reaidi P. Rosenberg, M, Gangnon RE, Stout NK. (2011) The Impact of Detection and Treatment of Carcinoma In Situ on Breast Cancer Mortality. Cancer Epidemiol Biomarkers Prev (April 2011) 20; 720 http://cebp.aacrjournals.org/content/20/4/720.1
  • Virnig BA, Shamliyan T, Tuttle TM, Kane RL, and Wilt TJ (2009) Diagnosis and Management of Ductal Carcinoma in Situ (DCIS). Evidence Report/Technology Assessment No. 185 (Prepared
    by the Minnesota Evidence-based Practice Center under Contract No. 290-02-10064-I) https://www.ahrq.gov/downloads/pub/evidence/pdf/dcis/dcis.pdf.